Willow Biosciences Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was CAD 0.135 million compared to CAD 0.262 million a year ago. Net loss was CAD 3.6 million compared to CAD 3.15 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.03 a year ago.
For the six months, revenue was CAD 0.409 million compared to CAD 0.262 million a year ago. Net loss was CAD 8.37 million compared to CAD 6.12 million a year ago. Basic loss per share from continuing operations was CAD 0.07 compared to CAD 0.05 a year ago.